Functional MRI for prediction and monitoring of treatment response in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy or endocrine therapy with or without bevacizumab
- Prosjektnummer
- 2010029
- Ansvarlig person
- Dag Rune Olsen
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 6. Treatment Evaluation
Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations.
Eur Radiol 2013 Apr;23(4):1027-33. Epub 2012 okt 31
PMID: 23111816 - Inngår i doktorgradsavhandlingen
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging.
Eur Radiol 2010 Dec. Epub 2010 des 3
PMID: 21127880 - Inngår i doktorgradsavhandlingen
Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
Acta Oncol 2010 Oct;49(7):914-21.
PMID: 20831478
Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Acta Oncol 2010 Apr;49(3):354-60.
PMID: 20397769 - Inngår i doktorgradsavhandlingen
Functional MRI for prediction and assessment of response to neoadjuvant treatment in breast cancer patients
- Disputert:
- juni 2013
- Hovedveileder:
- Therese Seierstad
- Oliver Geier Prosjektdeltaker
- Anne Fangberget Prosjektdeltaker
- Dag Rune Olsen Prosjektleder
- Therese Seierstad Hovedveileder
- Line Brennhaug Nilsen Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport